Skip to main navigation Skip to search Skip to main content

Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity

  • Stefan Lohse
  • , Sebastian Loew
  • , Anna Kretschmer
  • , J H Marco Jansen
  • , Saskia Meyer
  • , Toine Ten Broeke
  • , Thies Rösner
  • , Michael Dechant
  • , Stefanie Derer
  • , Katja Klausz
  • , Christian Kellner
  • , Ralf Schwanbeck
  • , Ruth R French
  • , Thomas R W Tipton
  • , Mark S Cragg
  • , Denis M Schewe
  • , Matthias Peipp
  • , Jeanette H W Leusen
  • , Thomas Valerius

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)413-417
Number of pages5
JournalBritish Journal of Haematology
Volume181
Issue number3
DOIs
Publication statusPublished - May 2018

Keywords

  • ADCC
  • CD20
  • IgA antibody
  • antibody therapy
  • myeloid effector cells

Cite this